Abstract
Purpose
The participation rates in cervical screenings are varying over different countries. This is only partly due to the availability of organized screening programs, as the rates are also varying between countries were such programs were implemented. For Germany the level of knowledge is low, and information are outdated. In order to improve the level of knowledge, we examined whether the participation rates in cervical screenings in a large German insurance population were changing over time, and whether these changes were different with respect to age and qualification of the participating women.
Methods
The analyses were based on the complete anonymised dataset of a large statutory health insurance in Lower Saxony, Germany, with case numbers between 940,827 (2006) and 1,044,797 (2011) women aged 20 years and older.
Results
Between 2006 and 2011 the overall annual participation rates were increasing from 44.8 to 47.6 %. The highest rates occurred in women with the highest qualification level, thus leading to increasing social differences over time. There was a peak in the age group of 25–29 years from annually 60.3 (2006) to 60.2 % (2011), and bi-annually from 77 to 77.1 % with constantly decreasing rates up to the age of 60. No substantial differences occurred between a 2- and a 3-year observation period.
Conclusions
Over time only small increases of participation rates in cervical screenings occurred. These findings may be interpreted in favor of population-based screenings within an invitation program.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Spence AR, Goggin P, Franco EL (2007) Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 45:93–106
Boyle P, Autier P, Bartelink H et al (2003) European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14:973–1005
Andrae B, Kemetli L, Sparén P et al (2008) Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100:622–629
Lönnberg S, Anttila A, Luostarinen T, Nieminen P (2012) Age-specific effectiveness of the finnish cervical cancer screening programme. Cancer Epidemiol Biomark Prev 21:1354–1361
Dugué PA, Lynge E, Bjerregaard B, Rebolj M (2012) Non-participation in screening: the case of cervical cancer in Denmark. Prev Med 54:266–269
Zucchetto A, Ronco G, Giorgi Rossi P et al (2013) Screening patterns within organized programs and survival of Italian women with invasive cervical cancer. Prev Med 57:220–226
Grillo F, Vallée J, Chauvin P (2012) Inequalities in cervical cancer screening for women with or without a regular consulting in primary care for gynaecological health, in Paris, France. Prev Med 54:259–265
Sasieni P, Castanon A, Cuzick J, Snow J (2009) Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. Br Med J 339:b2968
Arbyn M, Simoens C, Fabry V (2010) Analysis of individual health insurance data pertaining to pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 2002–2006). Scientific Insitute of Public Health, Brussels
Schneider V (2012) Gynäkologische Krebsvorsorge in Deutschland. Pathologe 33: 286–92
Kerek-Bodden H, Altenhofen L, Brenner G, Franke A (2009) Durchführung einer versichertenbezogenen Untersuchung zur Inanspruchnahme der Früherkennung auf Zervixkarzinom in den Jahren 2002, 2003 und 2004 auf der Basis von Abrechnungsdaten. Berlin: Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland
Jaunzeme J, Eberhard S, Geyer S (2013) Wie “repräsentativ” sind GKV-Daten? Demografische und soziale Unterschiede und Ähnlichkeiten zwischen einer GKV-Versichertenpopulation, der Bevölkerung Niedersachsens sowie der Bundesrepublik am Beispiel der AOK Niedersachsen. Bundesgesundheitsblatt 56: 447–54
Corp Stata (2013) Stata statistical software: release 13. Stata Corp, College Station
Bang JY, Yadegarfar G, Soljak M, Majeed A (2012) Primary care factors associated with cervical screening coverage in England. J Public Health 34:532–538
Patel A, Galaal K, Burnley C et al (2012) Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer 106:1753–1759
Sambamoorthi U, McAlpine DD (2003) Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Prev Med 37:475–484
Lavarreda SA, Brown ER, Bolduc CD (2011) Underinsurance in the United States: an interaction of costs to consumers, benefit design, and access to care. Annu Rev Public Health 32:471–482
Ronco G, Dillner J, Elfström KM et al (2013) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. doi:10.1016/S0140-6736(13)62218-7
Arbyn M, Verdoodt F, Snijders PJF et al (2014) Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. doi:10.1016/S1470-2045(13)70570-9
Acknowledgements
The work with this dataset was made possible by the Allgemeine Ortskrankenkasse Niedersachsen (AOKN), especially by Dr. Jürgen Peter and Dr. Sveja Eberhard who provided opportunities for using the health insurance data for scientific analyses.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Geyer, S., Jaunzeme, J. & Hillemanns, P. Cervical cancer screening in Germany: group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data. Arch Gynecol Obstet 291, 623–629 (2015). https://doi.org/10.1007/s00404-014-3421-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3421-3